Table 3.
Marginal effect | 95%CI | |
---|---|---|
CANTON | ||
Aargau (reference) | ||
Vaud | -0.040 | [-0.045 -0.034] |
Ticino | -0.260 | [-0.265 -0.255] |
PATIENTS' VARIABLES Female | 0.003 | [-0.001 0.007] |
Age: | ||
0-19 | 0.031 | [0.022 0.040] |
20-39 | 0.035 | [0.028 0.041] |
40-59 | 0.016 | [0.011 0.022] |
60-79 (reference) | ||
80+ | -0.005 | [-0.013 0.002] |
Optional health insurance deductible | 0.007 | [0.003 0.012] |
Out-of-pocket participation | 0.023 | [0.018 0.028] |
Treatment complexity: | ||
1-5 drugs | 0.014 | [0.009 0.020] |
6-10 drugs (reference) | ||
11-15 drugs | -0.009 | [-0.015 -0.004] |
16-20 drugs | -0.017 | [-0.024 -0.010] |
21+ drugs | -0.029 | [-0.037 -0.021] |
PHYSICIANS' VARIABLES Specialist prescriber | -0.032 | [-0.037 -0.027] |
Hospital prescriber | -0.131 | [-0.137 -0.125] |
SUBSTITUTION GROUPS' VARIABLES Number of generics: | ||
1-2 (reference) | ||
3-4 | 0.083 | [0.075 0.090] |
5-6 | 0.125 | [0.118 0.133] |
7+ | 0.085 | [0.076 0.095] |
Number of treated patients: | ||
1-1000 (reference) | ||
1001-2000 | 0.018 | [0.012 0.025] |
2001-3000 | 0.071 | [0.060 0.082] |
3001+ | 0.002 | [-0.006 0.010] |
Price of brand medication: | ||
1st quintile | 0.031 | [0.023 0.039] |
2nd quintile | -0.001 | [-0.011 0.009] |
3rd quintile (reference) | ||
4th quintile | 0.012 | [0.004 0.020] |
5th quintile | -0.011 | [-0.019 -0.002] |
Relative price difference: | ||
1st quintile | -0.050 | [-0.058 -0.042] |
2nd quintile | -0.028 | [-0.036 -0.020] |
3rd quintile (reference) | ||
4th quintile | 0.004 | [-0.004 0.013] |
5th quintile | 0.038 | [0.028 0.048] |
Original with special galenic form | -0.077 | [-0.088 -0.066] |
At least one drug sold under license | -0.051 | [-0.058 -0.043] |
Multiple package sizes | -0.039 | [-0.045 -0.032] |
Notes:
* p < 0.05 ** p < 0.01 *** p < 0.001
The marginal effect for discrete and factor variables is the discrete change from the reference level